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Legionellosis are infections caused by Legionella spp. The diagnosis of high-risk patients should rely on 
microbiological tests which allow the establishment of this infection etiology. Cases have to be confirmed 
through the available diagnostic methods which have different performances, sensitivity, specificity, error 




Assess the accuracy of urinary antigen detection, direct fluorescent antibody (DFA) staining, serological 
testing, Protein Chain Reaction (PCR) versus culture (reference standard), in patients suspected to be infected 




We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library and 




Observational studies were included, comparing the index tests with culture in patients suspected to be 
infected with Legionella or patients with laboratory confirmed LD. 
 
Data collection and analysis 
 
Two authors independently assessed the trials and extracted data. Data was analysed using statistical software 





Five studies met the inclusion criteria. All studies evaluated PCR and DFA tests to detect Legionella in clinical 
specimens, comparing it with culture (reference standard) and were included in meta-analysis. PCR sensitivity 
and specificity ranged from 56% to 100% and from 89% to 100%, respectively. The pooled sensitivity was 
74% (95% IC 67%-80%), and the specificity 97% (95%IC 96%-80%). DFA sensitivity varied from 33% to 
44% and the specificity from 100% the pooled sensitivity was 40% (95% IC 21%-61%) and the specificity 




This review demonstrates that PCR have a high sensitivity and specificity for early diagnosis of LD.  However 
standardization  is   required  for   biological  samples.  Although  this,  culture  is   always  required  for 
epidemiological studies, strains molecular typing and antibiotic sensibility evaluations if needed. 
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B A C K G R O U N D 
 
Description of the Condition 
 
Legionellosis are infections caused by Legionella spp. 
Classically presents two distinct forms: Legionnaires’ 
disease (LD), a serious and potentially life- 
threatening illness which includes pneumonia, and 
Pontiac Fever, a milder febrile flu-like illness without 
pneumonia. (Zaragoulidis 2011). Most  of  the  LD 
patients present fever, non-productive cough, 
headache, myalgias and dyspnea. Clinical syndroms 
may  include  diarrhea,  nausea,  vomiting, liver  and 
kidney dysfunction, thrombocytopenia, 
hypophosphatemia and neurological disorders. The 
diagnosis of high-risk patients should rely on 
microbiological tests which allow the establishment 
of  etiology  of  this  infection  (Zaragoulidis  2011; 
Fields 2002). These tests should be specifically 
requested, as they are not routinely performed in 
laboratory (Murdock 2010). All cases have to be 
confirmed through the available methodology that 
includes, classical culture (gold standard), direct 
fluorescent antibody assay  (DFA), urinary antigen 
detection, serological assay and nucleic acid 
amplification (Silva  1996).  Those  techniques have 
different performances, sensitivity, specificity, error 
causes, limitations, and needs a careful interpretation 
(Fields 2002). 
A confirmed case requires one of the following 
criteria:    isolation  of  Legionella  spp.  in  a  clinical 
sample, antibody titer increase (4x) being the second 
titer not less than 128 for Legionella pneumophila 
serogroup 1 or urinary positive antigen for Legionella 
pneumophila serogroup 1 (Silva 1996). 
 
 
Epidemiology and Pathogenesis 
 
Legionella spp are pleomorphic Gram negative motile 
rods. They are intracellular parasites, strict aerobic, 
nutritionally demanding, cysteine  require  for  their 
growth. Some species are able to survive between 20 
° C and 45 ° C. Legionella species are ubiquitous in 
both natural and artificial aquatic environments. 
(Zaragoulidis 2011). However these bacteria 
infrequently cause disease. There must be a 
combination  of  factors  to  further  LD  infection. 
They include: the proper environmental conditions 
allowing virulent strains survival; a way of bacteria 
dissemination such as aerosolization; and inhalation 
of an infectious dose by a susceptible host. The main 
mode of transmission of these infections is the 
airway, inhalation of aerosols containing Legionella, or 
micro aspiration of contaminated water. There is no 
evidence of direct transmission from person-to- 
person (WHO 2011). Host risk factors associated 
with this infection are diverse, such as male gender, 
older  than  50  years,  smoking,  underlying 
predisposing conditions as chronic obstructive 
pulmonary disease, immunosupression associated 
with  cancer  or  solid  organ  transplantation  and 





Severe infections are frequently associated with 
immunocompromised patients. According to 
European Legionnaires´ Disease Surveillance 
Network (2013), although under-diagnosed and 
under-reported in all countries, in European 
countries, the overall notification rate was 11.5 per 
million inhab in 2012, whereas 69% are for cases of 
community-acquired disease, 12% travel -associated 
(within and outside the country), 8% healthcare 
associated and 3% of others settings. World Health 
Organization data suggest a high mortality rate 40- 
80%            associated            with            untreated 
immunocompromised patients (ELDSNet 2013). 
These data can be reduced to 5 to 30% through 
appropriate case management and depending on the 










Culture remains the reference method, Gold 
Standard, for Legionella spp, diagnosis with a 
specificity of 100%. Estimated sensitivity culture of 
clinical samples range from <10% to 80%, probably 
due previously empirical therapies that may inhibit 
growth in vitro. Culture diagnosis requires special 
media, adequate processing of specimens and 
technical expertise. The  standard medium used  is 
buffered charcoal yeast extract (BCYE) agar which 
provides iron and L-cysteine, with or without 
antibiotics, essentials for  the  growth of  Legionella. 
The appearance of Legionella on the surface of BCYE 
is characteristic: colonies resembling cut glass, when 
observed with magnifying glass (40x). Two days are 
usually  required  for  recognition  of  colonies,  but 
most Legionella colonies can only be detected after 3- 
5 days. (Mandell 2010; Silva 1996). 
 
 
Direct fluorescent antibody (DFA) staining 
 
DFA is a diagnostic test used for detection of 
Legionella pneumophila antigen directly in respiratory 
specimens and tissue samples. This technique has 
the  advantage  of  providing  a  result  within  2-3h 
which allows preliminary information useful in 
guiding treatment. Method with high specificity 
estimated at 94% although can be less specific with 
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inexperienced laboratory personnel, due the 
possibility of cross-reactions with other bacteria, 
including Pseudomonas spp. Values of sensitivity have a 
range of 25 to 70% once is technical demanding and 
depending on sputum sample. For this all reasons 
DFA is only considered a probable diagnosis of 
Legionella infections according to  European Working 
Group for Legionella Infections (EWGLI) (Fields 
2002; Murdoch 2003; Pedro-Botet 2011). 
 
 
Urinary antigen detection 
 
Urinary antigen detection used worldwide allows a 
confirmed diagnosis of Legionella pneumophila 
serogroup 1. Up to date, several commercially 
available tests have been developed for detection of 
Legionella pneumophila serogroup 1 antigen in urine, 
such as Enzyme Immunoassay (EIA) and 
Immunochromatographic (IC) assays. The EIA 
method is not  used in routine because is laborious 
and require specific equipment, on other hand IC is 
a rapid technique, requires no laboratory equipment 
and the results are obtained within 15 minutes 
(Murdoch   2003;   WHO   2011).   This   test   has 
specificity  (100%)  and  sensitivity  (70-90%)  which 
can be enhanced after a prolonged incubation time 





Detection of  antibodies of  Legionella in  serum  by 
indirect immunofluorescence (IFA) has a sensitivity 
range between 78 to 91% and specificity of 90% 
(Diagnosis of Legionella infection). There are some 
limitations,  such  as  the  need  to  obtain  serum 
samples taken at intervals of at least 3-4 weeks to 
check seroconversion – a 4-fold or greater increase 
in   antibody  titer.   Other  disadvantages  are   the 
inability to accurately detect all Legionella species and 
serogroups, registration of cross-reactions and 
variations in the kinetics of the antibody, which is 
poorly known (Fields 2002; WHO 2011). 
 
 
Nucleic Acids amplification 
 
PCR has been successfully used to detect Legionella 
DNA in clinical and environmental samples and are 
promising  for  a  rapid  diagnosis  of  legionellosis. 
There are several techniques available using rRNA 
(ribosomal RNA): rRNA 5S, 16S rRNA gene mip 
(macrophage infectivity potentiator) among others, 
which  makes  a  non  standardized method  due  to 
different degrees of sensitivity and specificity. 
Therefore, any result should be interpreted as a 
probable diagnosis (Project). The technique of real 
time PCR (RT-PCR) combined with hybridization 
probe enables the specific amplification of Legionella 
DNA,   providing   results   in   a   short   time   and 
confirming    the    reduction    cases    of    cross- 
contamination (Murdock 2010). 
 
 
Why is important to do this review 
 
It is extremely important to obtain a rapid and 
effective diagnosis of LD cases to provide timely and 
appropriate therapy, to decrease the morbidity and 
mortality rates and to reduce costs associated with 
this  disease. Culture  is  the  reference  standard  for 
LD,  although  essential  in  clinical  and 
epidemiological research, is time consuming and has 
a low sensitivity not allowing a rapid diagnosis in a 
severe case of illness. We, therefore, conducted a 
systematic review of the literature to estimate the 
accuracy of several diagnostic tests compared with 





O B J E C T I V E S 
 
 
To assess the accuracy of urinary antigen detection, 
direct fluorescent antibody (DFA) staining, 
serological testing, Protein Chain Reaction (PCR) 
versus culture (reference standard), in patients 
suspected of  suffering from  LD  or  patients  with 









Criteria for selecting studies for this 
review 
 
Types of studies 
 
We aimed to include studies published in English. 
Studies   were   considered   eligible   if   diagnostic 
methods were evaluated in the same patient (direct 
comparison) against the reference standard- culture; 
absolute  numbers  of  true-positive,  false-negative, 
true-negative, and  false-positive observations were 





Patients  suspected  of  infection  with  Legionella  or 
patients with laboratory confirmed LD. 









Urinary antigen detection; 
Direct fluorescent antibody (DFA) staining; 
Serological testing; 





Any of the listed index tests were compared with the 


















We  identified  eligible  studies  by   searching  the 
following databases: 
 
    The    Cochrane    Central    Register    of 
Controlled Trials (CENTRAL) in The 
Cochrane Library using the search strategy 
in Appendix 1; 
    MEDLINE  (PubMed)  using  the  search 
strategy in Appendix 2. 
 
Both searches were limited to studies published in 
the English language. We also restricted our search 
to published studies. We screened titles, keywords 
and abstracts of retrieved articles from the electronic 
searches, and obtained full copies of reports of 
potentially relevant trials for further assessment. 
 
 
Searching other resources 
 
We handsearched the reference lists of all primary 
studies identified by the initial search. 
 
 
Data collection and analysis 
 
Selection of studies 
 
Two   review   authors   (EC,   DA)   independently 
assessed the studies identified by the search strategy, 
to identify potentially relevant trials for the review 
according to the criteria outlined above. We resolved 
disagreements about inclusions by discussion. 
 
Data extraction and management 
 
A  standardised data extraction form  was  used  to 
abstract study design features and results data from 
each publication. For each study data were extracted 
independently by two authors (EC, DA). We 
extracted: year of publication, aim of study, study 
design, clinical setting, population, outcomes and the 
Quality Assessment of Diagnostic Accuracy Studies 
(QUADAS) methodological items (Reitsma, 2009). 
We also recorded the numbers of true positives, true 
negatives, false positives and false negatives 
 
Assessment of methodological quality 
 
Methodological quality of included primary studies 
was  assessed  by  two  authors  using  a  modified 
QUADAS tool (Whiting 2003) that included 11 of 
the  14  mandatory  items,  representative  spectrum, 
acceptable   reference   standard,   acceptable   delay 
between     tests,     partial     verification     avoided, 
differential    verification    avoided,    incorporation 
avoided,  reference  standard  results  blinded,  index 
test  results  blinded,  relevant  clinical  information, 
uninterpretable    results    explained,    withdrawals 
explained.   The   operational   definitions   of   the 
QUADAS items are presented in Appendix 3. 
Extracted data were used to estimate sensitivity and 
specificity    and    to    investigate    the    diagnostic 
performance of each index test. 
 
 
Statistical analysis and data synthesis 
 
We extracted or derived data of diagnostic 
performance presented in  each  primary study for 
each index test. Data was analysed using statistical 
software, Review Manager 5.1. We constructed 2 X 
2 tables of true positive cases, false positive cases, 
false negative cases, and true negative cases. We 
considered patients with culture-positive results as 
true positives and patients with culture-negative 
results as true negatives when analysing the 
performance of each index test. We calculated 
sensitivity and specificity with 95% confidence 
intervals (CI) in each study and create forest plots 
and hierarchical summary receiver operating 
characteristic (HSROC) of sensitivity and specificity 
for each index test to investigate the diagnostic 
performance of each index test and heterogeneity in 
the  diagnostic  performance  of  each  index  test. 
Where there were studies of similar comparisons 
reporting the same outcome measures, a meta- 
analysis was undertaken. 
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Investigations of heterogeneity 
 
Factors  that  could  influence  diagnostic  accuracy 
other than true test performance included those 
relating to methodological quality and study design, 
characteristics of the underlying population, and 
characteristics of the index and reference test. We 
detailed and compared patient inclusion criteria for 
each included study. Factors such as differences in 
study population characteristics and test application 
(criteria for positive test) were used to explore any 
heterogeneity discovered in the analysis for the test, 
and to assess the impact of heterogeneity on the 
relative accuracy. As all studies in the analysis 
evaluated both tests in all patients this comparison 





R E S U L T S 
 
Results of the search 
 
The results of electronic database and handsearching 
are outlined in Figure 1. There were no 
disagreements between authors about either the 
number of studies eligible for inclusion, nor data 
results. The PubMed searches identified 2899 
citations and 78 from CENTRAL. Of these we 
considered 17 relevant to the purpose of our review 
and we retrieved 17 full-text articles for more details. 
We subsequently excluded 13 articles (see the 
Characteristics of excluded studies table). One 
additional study was included through the reference 
lists of eligible studies. Only five studies fulfilled our 
inclusion  criteria.  All  of  this  studies  compared 
culture with PCR and only one compared culture 
with PCR and DFA. The details of all studies 
included are reported in Characteristics of included 
studies. 
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Methodological quality of included 
studies 
 
All   included   studies   satisfied   the   QUADAS 
criteria of including study populations that 
represented the intended target population 
(patients suspected of having pneumonia caused 
by Legionella spp) and an acceptable reference 
standard (culture). In tree studies the delay 
between tests was not reported but likely to be 
only short delay (Cloud 2000; Lisby 1994; Pasculle 
1989).  In two studies there was no delay between 
tests because the same  samples were tested by 
both index test and reference standard (Edelstein 
1987; Hayden 2001). In all included studies, all 
patients who received the index test were also 
evaluated by the reference standard. No patients 
were verified with a second or third reference 
standard   because   disease   status   (LD)   was 





was therefore also avoided in all studies. 
Incorporation bias; which occurs when the index 
test is incorporated in a composite reference 
standard, often leading to overestimation of 
diagnostic test accuracy, was not present in any 
study. It was not reported if culture results were 
known at the time of index test in four studies 
(Cloud 2000; Hayden 2001; Lisby 1994; Pasculle 
1989). It was not reported if index test results 
were known at the time of culture in tree studies 
(Cloud 2000; Hayden 2001; Pasculle 1989) In all 
included  studies  the  data  available  during  the 
study of diagnostic test accuracy was the same as 
that which would have been available in normal 
clinical practice. There were no incomprehensible 
results in any included study. There were no 
withdrawals from the studies. 
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Figure 3. Methodological quality summary of studies: review authors’ judgments about 
each methodological quality item for each included study using the Quality Assessment of 
























Hayden 2001 a 
 
Hayden 2001 b 
 
Hayden 2001 c 
 









We identified 5 studies that evaluated PCR e DFA 
tests, a total of 1457 clinical samples from patients 
suspected of having pneumonia caused by 
Legionella  spp.   All   studies   were   designed   to 
evaluate PCR and DFA tests to detect Legionella in 
clinical specimens, comparing it with culture 
(reference standard). Forest plot of the study 
estimates of sensitivity and  specificity for PCR 
and DFA is shown in Figure 4. 
Figure 5 depicts the SROC plot of sensitivity and 
specificity, arranged by test comparison, for all 
studies identified and included in the meta- 
analysis. 
Factors such as patient characteristics, study 
design, test application (criteria for positive test) 
and study quality factors demonstrate no 








Figure 4. Forest plots PCR results for LD. 
The squares represent the sensitivity and specificity of one study, the black line its 
















1.00 [0.89, 1.00] 
Specificity 
0.93 [0.89, 0.97] 
Sensitivity   Specificity  
Edelstein 1987 63 2 49 228 0.56 [0.47, 0.66] 0.99 [0.97, 1.00]      
Hayden 2001 a 9 0 0 10 1.00 [0.66, 1.00] 1.00 [0.69, 1.00]      
Hayden 2001 b 7 0 0 12 1.00 [0.59, 1.00] 1.00 [0.74, 1.00]      
Lisby 1994 1 6 0 51 1.00 [0.03, 1.00] 0.89 [0.78, 0.96]      
Pasculle 1989 31 20 2 756 0.94 [0.80, 0.99] 0.97 [0.96, 0.98]      








Hayden 2001 c 
Hayden 2001 d 
TP   FP 
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7     0 
FN  TN 
6   10 
9     8 
Sensitivity 
0.33 [0.07, 0.70] 
0.44 [0.20, 0.70] 
Specificity 
1.00 [0.69, 1.00] 
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Figure 5. Summary receiver operator curve plot of sensitivity versus specificity for 
performance of PCR and DFA tests. Each symbol represents a study, with the height and 
width of each symbol being proportional to the inverse standard error of the sensitivity 











Protein Chain Reaction (PCR) 
 
PCR  was  compared  with  culture  in  5  studies 
(1457  clinical  samples)  (Cloud  2000;  Edelstein 
1987; Hayden 2001; Lisby 1994; Pasculle 1989). 
Figure 4 and 5, shows the Forest plots and SROC 
plots of the sensitivity and specificity estimates 
for  PCR  in  the  studies mentioned above. The 
sensitivity of PCR varied from 56% to 100% and 
the specificity from 89% to 100%. The pooled 
sensitivity was 74% (95% IC 67%-80%), and the 
specificity 97% (95%IC 96%-80%). 
Direct     fluorescent    antibody    (DFA) 
staining 
 
DFA was compared with gold standard culture 
method in 1 study (43 clinical samples) (Hayden 
2001). Figure 4 and 5, shows the Forest plots and 
SROC plots of the sensitivity and specificity 
estimates  for  DFA  in  the  studies  mentioned 
above. The DFA assay while requiring a similar 
time frame for testing was shown to have a 
sensitivity varied from 33% to 44% and the 
specificity   from  100%.  Pooled  sensitivity  was 
40% (95% IC 21%-61%) and the specificity 100% 






Summary of results 
 
Summary of results: Accuracy of diagnostic tests for legionnaires´ disease 
 
Review question: Any of the listed index tests where they were compared with the reference standard of 
Legionnaires´ disease 
Patient population: 
Patients suspected of suffering from LD or patients with laboratory confirmed LD 
Geographical location: Investigations performed in hospital or in Laboratory 
Index test : 
Direct fluorescent antibody (DFA) staining; 
Urinary antigen detection (immunochromatography); 
Serological testing; 
Protein Chain Reaction (PCR) 
Reference standard: Culture 





Limited number of included studies (5 studies); some studies had small samples size; only PCR and 
DFA were evaluated in detail. No studies were found investigating urinary antigen detection 
(immunochromatography) and serological testing as all studies in the analysis evaluated both tests in 
all patients this comparison should not be biased by differences between the studies. 
 
Results  
PCR  DFA  Summary effect (95% CI) 
TP 142 TP 
 



























DFA                    
1.0 (0.81-1.0) 
Specificity 
Total 1499 Total 43  
Conclusions and comments 
PCR is an attractive test, sensitive specific and convenient, we need further studies to approach the place 
this PCR test in the diagnosis of multifaceted atypical pneumonia. The availability of real-time PCR offers 
the potential for dramatically increasing the speed with which Legionellosis can be diagnosed. 
The DFA assay, while was shown to have a relatively low sensitivity (40%), allows for a probable diagnosis. 
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Applicability of tests in clinical practice 
We reviewed the diagnostic accuracy of PCR comparing it to culture, the reference method for 
Legionnaires ́ disease. There is evidence that PCR is a sensitive and specific test, valuable for the detection 
of cases of Legionelosis and it is likely that in the near future PCR is a test of choice in all laboratories. 
Costs 




Note: CI: confidence interval; DFA: direct fluorescent antibody; FN: false negative; FP: false positive; PCR: 




D I S C U S S I O N 
 
The diagnostic methods have been improved since 
Legionella pneumophila was first described; there are 
high sensitivity and specificity tests that allow a 
rapid   and   effective   diagnosis   in   laboratorial 
routine. An early diagnosis of LD is crucial for a 
therapeutic  decision  since  many  first-line 
antibiotics commonly used for bacterial 
pneumonias management (i.e., beta-lactams) are 
ineffective against Legionella species. We conducted 
a systematic review of the accuracy of different 
diagnostic tests for Legionnaires’ disease compared 
to the gold standard, culture method. This 
systematic  review  found  a  relative  scarcity  of 
studies that met the inclusion criteria and only five 
studies fulfilled our inclusion criteria. All studies 
compared PCR, and only one compared PCR and 
DFA  to  culture. These  primary  studies provide 
evidence to evaluate the performance of the tests 
for LD. 
Cloud (Cloud, 2000),    evaluated 186 respiratory 
samples   from   patients   suspected   of   having 
pneumonia caused by Legionella spp., 31 sputum 
specimens,  66  bronchial  washing  specimens,  74 
bronchoalveolar lavage (BAL) specimens, 8 pleural 
fluid specimens, and 7 lung tissue specimens.   26 
respiratory   samples   (13   BAL,   7   sputum,   4 
bronchial washing, and 2 pleural fluid specimens) 
were   spiked   in   order   to   contain   a   final 
concentration   of   approximately   102   to   103 
organisms of L. pneumophila (ATCC 33512) per ml. 
A PCR assay was developed, in which the target 
for the test is the 16S rRNA gene, which exists in 
multiple copies per genome, thus improving the 
sensitivity of detection. Several medically relevant 
Legionella   species   including   L.   pneumophila,   L. 
micdadei, L. bozemanii, L. longbeachae, L. feeleii, and L. 
dumoffii can be detected without the use of culture. 
Edelstein (Edelstein, 1987), studied a total of 112 
clinical  specimens  (positive  samples  previously 
selected)  collected  from  64  patients    that  were 
used as positive samples. At the same time, a total 
of 230 negative specimens were selected; Negative 
samples  were  confirmed  by  culture  and  DFA 
techniques.  These  samples  were  selected  from 
patients with clinical suspicion of LD and were 
cryopreserved at -70°C for 2 to 8 years without 
specific preservative. All 342 clinical samples were 
randomly  included  in  the  study  by  computer- 
generated random-number list.   True  identity of 
the samples was unknown. Gen Probe developed 
hybridization probes directly on clinical specimens 
-   Gen-Probe   Rapid   Diagnostic   System   for 
Legionella spp. This kit contains cDNA labeled with 
125I, which specifically hybridizes to the rRNAs of 
all   Legionella species. 
Pasculle (Pasculle 1989) studied a total of 809 
clinical specimens, mostly sputum samples, which 
were submitted to their laboratory between 2 April 
and 31 October 1987 for Legionella testing.  They 
performed culture, DFA, and DNA probe testing 
(Gen-Probe kit used by Edelstein in the previously 
mentioned study). 
Lisby   (Lisby   1994)   studied   routine   clinical 
bronchial fluid samples from 51 patients (30 male 
and 21 female, median age 61 years) with clinical 
suspicion of Legionnaire's disease diagnosis were 
performed by culture technique.   Thirty-seven 
children (median age 1 year) with a suspected viral 
pulmonary infection were included as negative 
controls. A polymerase chain reaction (PCR) assay 
for the detection of Legionella spp in clinical 
bronchial fluid samples was developed DNA from 
patients and controls were analyzed blindly. The 
PCR was able to detect a 375 bp fragment of the 
16S RNA gene, equivalent to 10 cfu in simulated 
clinical bronchial fluid and blood samples. 
Hayden (Hayden, 2001) studied a total of 43 
archived specimens from 35 patients including 19 
bronchoalveolar lavage (BAL) specimens, and 24 
formalin-fixed, lung biopsy specimens. BAL 
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specimens were tested by LightCycler PCR (LC- 
PCR)   methods,   and   by   a   direct   fluorescent 
antibody (DFA) assay, which detects L. pneumophila 
serogroups 1 to 6 and several other Legionella 
species. Tissue sections were tested by the two LC- 
PCR methods, by DFA, by an in situ hybridization 
(ISH) assay, specifically designed to detect L. 
pneumophila, and by Warthin-Starry (WS) staining. 
The results were compared to the “gold standard” 
method of bacterial culture. The samples were 
frozen and randomly selected. Legionella species 
detection, directly from clinical specimens, were 
performed by real-time PCR (LightCycler (Roche 
Molecular Biochemicals, Indianapolis, Ind.), using 
a primer-probe sets   tested against a total of 17 
different known strains. The target was a Legionella 
genus (5S rDNA) of all species, with all L. 
pneumophila serotypes detected by the L. 
pneumophila species-specific (mip) primers and 
probes. Optimized PCR conditions, as well as 
dilution studies to evaluate sensitivity and plasmid 
construction, were performed using using L. 
pneumophila serogroup 1 (ATCC 33152). Other 
strains of Legionella, used for validation of the assay 
included L. pneumophila serogroups 1 to 6, as well 
as several other strains of Legionella, representing 
the most commonly isolated non-L. pneumophila 
species. With conventional culture serving as the 
“gold standard,” the results of LC-PCR were 
compared  to  direct  fluorescent antibody  (DFA) 
assay for the detection of Legionella species in BAL 
specimens, and open lung biopsy specimens. 
According to QUADAS items, these studies were 
classified    as    having    high    quality 
methodology. When  the  reference  standard  was 
interpreted knowing the index test results, this may 
have led to the overestimation of diagnostic test 
accuracy the studies. 
Our review showed that PCR have high levels of 
sensitivity and specificity to detect all species of 
Legionella. Our key findings are presented in 
Summary of results. The sensitivity of PCR varied 
from 56% to 100% and the specificity from 89% 
to 100%. The pooled sensitivity was 74% (95% IC 
67%-80%), and the specificity 97% (95%IC 96%- 
80%). The sensitivity of DFA varied from 33% to 
44% and specificity was 100%. The pooled 
sensitivity was 40% (95% IC 21%-61%) and the 
specificity 100% (95% IC 81%-100%). 
The gold standard technique has low sensitivity, of 
approximately 50 to 60% related to the fastidious 
nature of the bacteria, which requires 3-5 days to 
form visible colonies and must be examined by an 
experienced professional. There are even species 
that do not grow in the culture medium. The fact 
that the majority of patients have already started 
antibiotic therapy prior to sample collection is also 
associated with the low sensitivity of the gold 
standard. All these problems cause a delayed 
laboratory response, not responding in time to the 
demands of the diagnosis of a serious condition. 
Although the above characteristics, culture have 
100% specificity for LD diagnosis. 
In conclusion, we identified only a limited number 
of studies that directly compared PCR and DFA 
versus culture for the early detection of LD. The 
overall methodological quality of these studies was 
high to moderate.  Due to the small number of 
included studies, we could not reach a definitive 
conclusion. However, according to the results 
obtained in this review, DFA was shown to have a 
relatively low sensitivity. PCR is an attractive test, 
easy  to  perform,  providing  high  sensitivity  and 






Implications for practice 
 
PCR has a high sensitivity and specificity, allowing 
the diagnosis of infections caused by Legionella spp. 
This  review  seems  to  demonstrate that  in  near 
future, PCR will be the test that meets the 
requirements of quickly and efficiently needed for 
a rapid diagnosis of Legionella infections. However 
standardization is required for biological samples. 
Culture is always required for epidemiological 
studies, strains molecular typing and allows 
antimicrobial susceptibility testing whenever 
required. 
 
Implications for research 
 
Additional  well  designed  studies  are  needed  in 
order to achieve the best standard test that enables 
optimization of Legionella infection diagnostic. The 
results of such experiments would be very helpful 
to clinicians and microbiologists, which are 
currently faced with different tests and might help 
to establish standard methods that can be used not 
only in research but in daily routine practice. 
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C H A R A C T E R I S T I C S   O F   S T U D I E S 
 






Clinical features and settings                   Clinical features 




Associated Regional and University Pathologists Diagnostic Infectious 
Diseases Laboratory, Salt Lake City, Utah 
Participants                                             212 respiratory samples 
Study design                                            Observational 
Index test                                                PCR 
Reference standard                                  Culture 





Table of Methodological Quality 
 
 




Acceptable reference standard? 
All tests 
Acceptable delay between tests? 
All tests 
Partial verification avoided? 
All tests 





Reference standard results blinded? 
All tests 
Index test results blinded? 
All tests 
Relevant clinical information? 
All tests 
 




Yes                                 Patients suspected of having pneumonia caused by 
Legionella spp. 
Yes                                 Culture, the gold standard for LD. 
No                                  Not reported. 
Yes                                 All patients were evaluated by culture. 
 
Yes                                 This was not an issue in this study. Disease status 
(LD) was diagnosed only through culture. 
Yes                                 This was not an issue in this study. Disease 
status (LD) was diagnosed only through 
culture. 
No                                  Not reported. 
No                                  Not reported. 
Yes                                 Relevant clinical information was provided 
regarding the performance and analysis of both the 
index and reference tests. 
Yes                                 No results were reported to be uninterpretable. 
Yes                                 No missing patients. 










Clinical features and settings                       Clinical features 
Patients suspected of having Legionnaires disease. 
Settings 
Not reported but likely to be at Department of Pathology and Laboratory 
Medicine, Hospital of the University of Pennsylvania, Philadelphia 
Participants                                                 342 clinical samples 
Study design                                               Observational 
Index test                                                   PCR 
Reference standard                                     Culture 




Table of Methodological Quality 
 




Acceptable reference standard? 
All tests 
Acceptable delay between tests? 
All tests 
Partial verification avoided? 
All tests 






Reference standard results blinded? 
All tests 
Index test results blinded? 
All tests 
Relevant clinical information? 
All tests 
 





Yes                                    Patients suspected of having pneumonia caused by 
Legionella spp. 
Yes                                    Culture, the gold standard for LD 
 
Yes                                    The same samples were tested by both index test 
and reference standard 
Yes                                    All patients were evaluated by culture 
 
Yes                                    This was not an issue in this study. Disease status 
(LD) was diagnosed only through 
culture 
Yes                                    This was not an issue in this study. Disease 
status (LD) was diagnosed only through 
culture 
Yes                                    Technicians performing the assay had no knowledge 
of the true identity of the samples 
Yes                                    Technicians performing the assay had no knowledge 
of the true identity of the samples 
Yes                                    Relevant clinical information was provided 
regarding the performance and analysis of 
both the index and reference tests 
Yes                                    No results were reported to be uninterpretable. 





Clinical features and settings  Clinical features 
Positive Legionella culture specimens and culture- negative for Legionella 
Setting 
Mayo Clinic, Rochester, Minnesota 
 
Participants  A total of 43 archived specimens from 35 patients were evaluated 
Study design Observational 
Index test  PCR and Direct fluorescent antibody (DFA) staining; 
 
Reference standard  Culture 
Outcomes  True positive, True negative, False positive and False negative results, 
Sensitivity, Specificity  
Item  Authors´judgement  Description 
Representative spectrum? 
All tests 
 Yes  Patients suspected of having pneumonia caused by 
Legionella spp.  
Acceptable reference standard? 
All tests 
 Yes  Culture, the gold standard for LD 
   
Acceptable delay between tests? 
All tests 
 Yes  The same samples were tested by both index test 
and reference standard  
Partial verification avoided? 
All tests 
 Yes  All patients were evaluated by culture 
   
Differential verification avoided? 
All tests 
 Yes  This was not an issue in this study. Disease status 






 Yes  This was not an issue in this study. Disease 




Reference standard results blinded? 
All tests 
 No  Not reported 
   
Index test results blinded? 
All tests 
 No  Not reported 
  
Relevant clinical information? 
All tests 
 Yes  Relevant clinical information was provided 
regarding the performance and analysis of 
both the index and reference tests 
 
 
Uninterpretable results reported? 
All tests 




 Yes  No missing patients. 
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Clinical features and settings                   Clinical features 
Patients with clinical findings suggestive of Legionnaire's disease 
Settings 
Department of Clinical Microbiology, Herlev Hospital, Denmark 
Participants                                             88 Bronchial fluid samples from 51 patients with clinical findings suggestive 
of Legionnaire's disease 
Study design                                            Observational 
Index test                                                PCR 
Reference standard                                  Culture 





Table of Methodological Quality 
 
 




Acceptable reference standard? 
All tests 
Acceptable delay between tests? 
All tests 
Partial verification avoided? 
All tests 





Reference standard results blinded? 
All tests 
Index test results blinded? 
All tests 
Relevant clinical information? 
All tests 
 




Yes                                 Patients suspected of having pneumonia caused by 
Legionella spp. 
Yes                                 Culture, the gold standard for LD. 
No                                  Not reported.. 
Yes                                 All patients were evaluated by culture. 
 
Yes                                 This was not an issue in this study. Disease status 
(LD) was diagnosed only through culture. 
Yes                                 This was not an issue in this study.Disease 
status (LD) was diagnosed only through 
culture. 
No                                  Not reported. 
Yes                                 Not reported. 
Yes                                 Relevant clinical information was provided 
regarding the performance and analysis of both the 
index and reference tests. 
Yes                                 No results were reported to be uninterpretable. 
Yes                                 No missing patients. 










Clinical features and settings                 Clinical features 
Patients suspected of having Legionnaires disease. 
 
Settings 
Clinical Microbiology Laboratory, Presbyterian-University Hospital, 
Pittsburgh, Pennsylvania 
Participants                                           809 clinical specimens 
Study design                                          Observational 
Index test                                              PCR 
Reference standard                               Culture 




Table of Methodological Quality 
 




Acceptable reference standard? 
All tests 
Acceptable delay between tests? 
All tests 
Partial verification avoided? 
All tests 




Reference standard results blinded? 
All tests 
Index test results blinded? 
All tests 
Relevant clinical information? 
All tests 
 




Yes                               Patients suspected of having pneumonia caused by 
Legionella spp. 
Yes                               Culture, the gold standard for LD 
No                                Not reported. 
Yes                               All patients were evaluated by culture 
 
Yes                               This was not an issue in this study. Disease status (LD) 
was diagnosed only through culture 
Yes                               This was not an issue in this study. Disease status (LD) 
was diagnosed only through culture 
No                                Not reported. 
No                                Not reported. 
Yes                               Relevant clinical information was provided regarding 
the performance and analysis of both the index and 
reference tests 
Yes                               No results were reported to be uninterpretable. 
Yes                               No missing patients. 
 
Characteristics of excluded studies 
 
 
Study  Reason for exclusion 
Elveradl 2013  The reference Standard includes not only the culture 
Finkelstein 1993  The reference Standard includes not only the culture; No 
adequate outcome  
Morozumi 2006  No adequate outcome 
Diederen 2008  The reference Standard includes not only the culture 
Laussucq 1988  Not a diagnostic accuracy design 
Lindsay 2004  The reference Standard includes not only the culture 
Kasandjian 1997  Reference Standard not apply to all patients 
Bangsborg 1990  Not a comparison with reference standard; No adequate 
outcome  
Chiba 1998  No adequate outcome 
Formica 2001  Not a comparison with reference standard; No adequate 
outcome  
Van Der Eerden 2005  Not a comparison with reference standard; No adequate 
outcome  
Kawanami 2011  Isolated case 
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A D D I C T I O N A L   T A B L E S 
 
 
QUADAS methodological items and operational definitions 
 
 
Methodological variable                                             
Operational definition/information required from each 
study 
 
1. Representative spectrum (spectrum bias)                       When included patients did not represent the intended targeted 
population, this may have led to an under- or overestimation of 
diagnostic accuracy depending on the difference between the 
targeted and included populations. The target spectrum in our 
review was patients suspected of suffering from LD or patients 
with laboratory confirmed LD. This was scored ’yes’ if study 
participants included only patients suspected of suffering from 
LD or patients with laboratory confirmed LD 
 
2. Acceptable reference standard                                   An imperfect reference standard may have resulted in 
misclassification of disease positives and disease negatives. For 
the purpose of this review, studies had an acceptable reference 
standard if they used culture as the reference standard 
 
 
3. Acceptable delay between tests (disease progression 
bias) 
Disease may have progressed to a more advanced stage if a 
significant time interval between index and reference tests was 
observed, thereby leading to disease progression bias. This was 





4. Partial verification avoided (verification bias)                 Partial verification bias usually leads to an overestimation of 
sensitivity, although its effect on specificity varies. This item was 
scored ‘yes’ if all patients who received the index test were also 




5. Differential verification avoided                                 This was scored ‘yes’ if no patients were verified with a second or 
third reference standard 
6. Incorporation avoided (incorporation bias)                    This bias usually leads to an overestimation of diagnostic test 
accuracy. Incorporation bias was deemed to have existed if the 
index test was incorporated in a composite reference standard. 
Studies were scored ‘yes’ if their classification of disease status 




7. Reference standard results blinded (information bias)    When the reference standard was interpreted knowing the index 
test results, this may have led to the overestimation of diagnostic 
test accuracy. Studies were scored ‘yes’ if blinding of the 
reference standard was explicitly stated in the article or if this was 
acknowledged by authors in subsequent personal 
communication. Otherwise, the studies were marked ‘unclear’, 
unless blinding was explicitly stated to be absent 
 
 
8. Index test results blinded (information bias)                  When the index test results were interpreted without the 
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knowledge of results of the reference standard, or with more 
information than in practice, this may have resulted in bias, 
usually leading to an overestimation 
of diagnostic accuracy. This item was scored ‘yes’ if blinding of 
the index test was explicitly stated in the article or if this was 
acknowledged by authors in subsequent personal 
communication. Otherwise, the studies were marked ‘unclear’, 
unless blinding was explicitly stated to be absent 
9. Relevant clinical information (information bias)             The availability of clinical data during interpretation of test 
results may have affected estimates of test performance. This 
item was scored ‘yes’ if the data available during the study of 
diagnostic test accuracy was the same as that which would have 
been available in normal clinical practice 
10. Uninterpretable results explained                             This item was scored ‘yes’ if uninterpretable results were 
explained or if there were no uninterpretable results present. This 
item was scored ’no’ if uninterpretable results were found but 
not explained 
11. Withdrawals explained                                             Excluding patients from the study may have led to an 
overestimation of diagnostic accuracy. This item was scored ‘yes’ 
if withdrawals were explained or if there were no withdrawals 
from the study. This item was scored ’no’ if there were 
withdrawals from the study, but these were unexplained 
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A P P E N D I C E S 
Appendix 1 
Search strategy for the Cocrhrane Central Register of Controlled Trials 
 
     “Legionella”,“Legionellosis”, 
     “Legionnaires’disease”, 
     “Legionella AND diagnosis”, 
     “Legionellosis AND diagnosis”, 







Search strategy for the MEDLINE (PubMed) 
 
     #1 (legionnaires´disease OR legionellosis OR legionella) AND microbiological-diagnosis 
     #2 (legionnaires´disease OR legionellosis OR legionella) AND microbiological-diagnosis AND study 
     #3 (legionnaires´disease OR legionellosis OR legionella) AND healthcare-associated AND diagnosis 
     #4 (legionnaires´disease OR legionellosis OR legionella) AND microbiological-methods 
     #5 (legionnaires´disease OR legionellosis OR legionella) AND culture AND study 
     #6 (legionnaires´disease OR legionellosis OR legionella) AND urinary-antigen 
